Training study to optimize training adaptions of endurance training through increasing intensity
Organizational Data
- DRKS-ID:
- DRKS00031445
- Recruitment Status:
- Recruiting complete, study complete
- Date of registration in DRKS:
- 2023-03-08
- Last update in DRKS:
- 2023-03-08
- Registration type:
- Retrospective
Acronym/abbreviation of the study
TRAIN
URL of the study
No Entry
Brief summary in lay language
This training study investigated the effects of 26 weeks of endurance training on cardiorespiratory fitness, with and without increasing training intensity. For this purpose, it was agroup based and individual response examined on a group level and on an individual level whether the endurance performance can be increased by increasing the intensity, if the energy consumption remains constant.
Brief summary in scientific language
In this work, cardiorespiratory fitness, established risk factors, and prognostic factors for cardiovascular disease of endurance training, were examined in the context of a longitudinal randomized training trial. For this purpose, two investigation questions were examined at the group -and individual-level. 1. Can cardiorespiratory fitness be increased by increasing training intensity for an energy-equivalent training stimulus? 2. Can a nonresponse rate be reduced or even eliminated through an increase in intensity with energy expenditure held constant?
Health condition or problem studied
- Free text:
- primary prevention; effect of physical activity in healthy subjects
- Healthy volunteers:
- Yes
Interventions, Observational Groups
- Arm 1:
- 16 healthy, untrained adults trained for 26 weeks with moderate intensity (3 days per week, 50 minutes per session, training intensity 55HRreserve)
- Arm 2:
- 16 healthy, untrained adults trained for 26 weeks with moderate intensity (3 days per week, 50 minutes per session, training intensity 55HRreserve). For 8 weeks at 70% HRreserve and then performed high-intensity interval training (4x4) for another 8 weeks.
Endpoints
- Primary outcome:
- Data were recorded three times at baseline, after 10 weeks, after 18 weeks and after 26 weeks of training. Cardiorespiratory fitness was measured by a) maximum oxygen uptake (VO2max), b) maximum running speed, c) running economy, d) submaximal heart rate, e) lactate kinetics. Measures were performed three times at baseline, after 10 weeks, 18 weeks and after 26 weeks of training. Testing procedures Three baseline exercise tests were performed for habituation and to assess day-to-day variability of V̇O2max. At basline all participants underwent a medical examination, blood sampling, resting and exercise electrocardiogram (ECG), and maximal cardiorespiratory exercise testing on a treadmill (type ELG 70, Woodway GmbH, Weil am Rhein, Germany). Before exercise testing, height and body weight were measured. Body fat percentage was assessed by a 10-site skinfold method with a Harpenden caliper. Resting heart rate (HRrest) and resting blood pressure (RRrest) were assessed in supine position after a ten minute resting period at the right and left arm. Gas exchange measurements were conducted continuously using a breath-by-breath system (MetaLyzer® 3B, Cortex Biophysik GmbH, Leipzig, Germany). Lactate samples were taken at rest, during each break between GXT stages, and during the post-exercise period (1st, 3rd, and 5th min) from the hyperaemised earlobe. An enzymatic-amperometric method was used to analyse the samples (Super GL, Rolf Greiner Biochemica, Flacht, Germany).
- Secondary outcome:
- Health related outcomes were measured by A) resting heart rate B) resting blood pressure C) body composition D) bloodmarkers (e.g. cholesterol). A, B, C, D were measured in both groups at baseline, after 10 weeks, 18 weeks and 26 weeks.
Study Design
- Purpose:
- Prevention
- Allocation:
- Randomized controlled study
- Control:
-
- Active control (effective treatment of control group)
- Phase:
- I
- Study type:
- Interventional
- Mechanism of allocation concealment:
- adaptiv stratified randomisation
- Blinding:
- No
- Assignment:
- Other
- Sequence generation:
- Stratification markers were age, gender and VO2max and response ton VO2max
- Who is blinded:
- No Entry
Recruitment
- Recruitment Status:
- Recruiting complete, study complete
- Reason if recruiting stopped or withdrawn:
- No Entry
Recruitment Locations
- Recruitment countries:
-
- Germany
- Number of study centers:
- Monocenter study
- Recruitment location(s):
-
- University medical center Institut für Sport- und Präventivmedizin Universität des Saarlandes Saarbrücken
Recruitment period and number of participants
- Planned study start date:
- No Entry
- Actual study start date:
- 2020-01-05
- Planned study completion date:
- No Entry
- Actual Study Completion Date:
- 2021-03-01
- Target Sample Size:
- 55
- Final Sample Size:
- 48
Inclusion Criteria
- Sex:
- All
- Minimum Age:
- 30 Years
- Maximum Age:
- 60 Years
- Additional Inclusion Criteria:
- 1) healthy 2) nonsmokers 3) training status, within the last 6 months, no regular endurance training and no other training-effective activity > 1 h/week; strength training < 2 units/week 4) never competitive sports 5) VO2max Männer < 50 ml * kg-1*min-1; Frauen < 45 ml * kg-1*min-1
Exclusion Criteria
1) BMI > 30 kg•m-2 2) resting blood pressure (RRrest) ≥ 160/100 mmHg) 3) total cholesterol ≥ 300 mg•dl-1 4) maximum oxygen uptake (V̇O2max) > 50 ml•kg-1•min-1 for men; > 45 ml•kg-1•min-1 for women 5) iron deficiency (Ferritin ≤ 34 ng•ml-1) 6) thyroid dysfunction (TSH ≤ 0.34 mU•l-1; ≥ 4.0 ng•ml-1) 7) medications with potential influence on target parameters (e.g. beta-blockers) and pregnancy 8) Internal or orthopedic diseases for which maximum exertion or regular running training is contraindicated.
Addresses
Primary Sponsor
- Address:
- Institut für Sport- und Präventivmedizin Universität des SaarlandesProf. Dr. med. Tim Meyer66123 SaarbrückenGermany
- Telephone:
- No Entry
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
- Investigator Sponsored/Initiated Trial (IST/IIT):
- Yes
Contact for Scientific Queries
- Address:
- Institut für Sport- und Präventivmedizin Universität des SaarlandesProf. Dr. med. Tim MeyerCampus, Geb. B8 266123 SaarbrückenGermany
- Telephone:
- +49 681-302 70400
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Contact for Public Queries
- Address:
- Institut für Sport- und Präventivmedizin Universität des SaarlandesProf. Dr. med. Tim MeyerCampus, Geb. B8 266123 SaarbrückenGermany
- Telephone:
- +49 681-302 70400
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Principal Investigator
- Address:
- Institut für Sport- und Präventivmedizin Universität des SaarlandesProf. Dr. med. Tim MeyerCampus, Geb. B8 266123 SaarbrückenGermany
- Telephone:
- +49 681-302 70400
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Sources of Monetary or Material Support
Institutional budget, no external funding (budget of sponsor/PI)
- Address:
- Institut für Sport- und Präventivmedizin Universität des Saarlandes66123 SaarbrückenGermany
- Telephone:
- No Entry
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Institutional budget, no external funding (budget of sponsor/PI)
- Address:
- Deutsche Hochschule für Prävention und Gesundheitsmanagement66123 SaarbrückenGermany
- Telephone:
- No Entry
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Ethics Committee
Address Ethics Committee
- Address:
- Ethikkommission bei der Ärztekammer des SaarlandesFaktoreistr. 466111 SaarbrückenGermany
- Telephone:
- +49-681-4003216
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- No Entry
Vote of leading Ethics Committee
- Vote of leading Ethics Committee
- Date of ethics committee application:
- 2019-09-25
- Ethics committee number:
- Ha 219/19
- Vote of the Ethics Committee:
- Approved
- Date of the vote:
- 2019-10-17
Further identification numbers
- Other primary registry ID:
- No Entry
- EudraCT Number:
- No Entry
IPD - Individual Participant Data
- Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
- No
- IPD Sharing Plan:
- The data is currently not available
Study protocol and other study documents
- Study protocols:
- No Entry
- Study abstract:
- No Entry
- Other study documents:
- No Entry
- Background literature:
- No Entry
- Related DRKS studies:
- No Entry
Publication of study results
- Planned publication:
- 2023
- Publikationen/Studienergebnisse:
- No Entry
- Date of first publication of study results:
- No Entry
- DRKS entry published for the first time with results:
- No Entry
Basic reporting
- Basic Reporting / Results tables:
- Baseline Characteristics + Flowchart
- Brief summary of results:
- No Entry